1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow IMGN151: new trials by email Literature Review of IMGN151 trials Research Report on IMGN151
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First in Human Study of IMGN151 in Recurrent Gynaecological Cancers IMGN151 - Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary | Phase 1 | Active not recruiting | AbbVie | 256 | 2023-01-11 | 2026-02-20 |
Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1) · Recurrence (1) · Uterine Cervical Neoplasms (1)
AbbVie (1)
Australia (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Ireland (1) · Italy (1) · Netherlands (1) · Spain (1) · United States (1)
2023 (1)